Paul Davis, Managing Director of Wanner International takes a deep dive into a technology which is widely used by the oil and gas and petrochem industries looking at how it is providing a solution to challenges in pharmaceutical manufacture.
Robert Newman, Chief Scientific Officer at FUJIFILM Irvine Scientific and Tom Fletcher, Director of Research and Development at FUJIFILM Irvine Scientific explore ways of optimising bioprocessing workflows.
Jinhyeok Jeong and John Thomas, Senior Directors of DP Inspection & Packaging and DP MSAT, explores the major areas of DP manufacturing that can accelerate timelines from development to commercialisation.
Dr. Peter Hamley, Chief Scientific Officer at Samsara Therapeutics, explores whether developments in therapeutics for neurodegenerative diseases are truly disease modifying or addressing the symptoms of a deeper problem.
Nicole Wakes, Senior Director Cell Line Development, and Simon Keen, Vice President Cell Line Development at Abzena, outline the strategies to overcome the challenges of developing BsAbs under increasing pressure for speed.
The adoption and implementation of pre-packed process-scale chromatography columns has emerged as a promising solution to improving overall processing efficiency while maintaining high levels of quality and reducing costs.
Aaron Moulin, Field Application Specialist at Purolite, explores the need for a straightforward, quality-by-design (QbD) led approach to switching chromatography resin suppliers.
Michael Franco, director, global biopharma sales at PSG Biotech, highlights the pain points that must be overcome in critical life science procedures and biopharmaceutical production operations.
